Eli M Wallace

This inventor holds 91 USPTO granted patents and 15 published patent applications, plus 13 CIPO patents and 33 EPO patents, primarily in Kinase Inhibitors (CPC class C07D401-12). Top assignees: Array Biopharma Inc., Peloton Therapeutics, Inc., Genentech, Inc.. Active years: 2003-2024.

USPTO Granted Patents = 91 (Patent Applications = 15)

% Patents Active = 54.9

CIPO Patents = 13 (Patent Applications = 4)

EPO Patents = 33 (Patent Applications = 25)

Average Co-Inventor Count = 6.1

ph-index = 14

Forward Citations = 701(Granted Patents)

Forward Citations (Not Self Cited) = 489(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Lyons, CO (US) (2003 - 2017)
Boulder, CO (US) (2011 - 2018)
Richardson, TX (US) (2013 - 2024)

Company Filing History:

Peloton Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

HIF-2-alpha

Mitotic Kinesins

Quinazoline Analogs

Aryl Ethers

Pyrrolopyridines

Serine/Threonine Kinase

Benzimidazole Derivatives

Pulmonary Arterial Hypertension

Cyclic Sulfone

Diabetes Mellitus

PIM Kinase

91 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49948 - Aryl ethers and uses thereof (2024-04-30),

2. 11174273 - Quinazoline analogs as receptor tyrosine kinase inhibitors (2021-11-16),

3. 10807948 - Aromatic compounds and uses thereof (2020-10-20),

4. 10786480 - Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof (2020-09-29),

5. 10597366 - Aryl ethers and uses thereof (2020-03-24),

6. 10335388 - Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof (2019-07-02),

7. 10278942 - Compositions for use in treating pulmonary arterial hypertension (2019-05-07),

8. 10221194 - Quinazoline analogs as receptor tyrosine kinase inhibitors (2019-03-05),

9. 10144711 - Aryl ethers and uses thereof (2018-12-04),

10. 10040767 - Benzimidazole derivatives and uses thereof (2018-08-07),

11. 10017482 - Mitotic kinesin inhibitors and methods of use thereof (2018-07-10),

12. 9969727 - Pyrrolopyridines as kinase inhibitors (2018-05-15),

13. 9969689 - Aryl ethers and uses thereof (2018-05-15),

14. 9908845 - Aryl ethers and uses thereof (2018-03-06),

15. 9896418 - Aryl ethers and uses thereof (2018-02-20),

Certainly. Here is an article about inventor Eli M Wallace:

Title: Unveiling the Innovations of Eli M Wallace

Introduction:

Eli M Wallace, a distinguished inventor based in Boulder, CO, has made significant contributions to the field of medicine and pharmaceuticals through his groundbreaking inventions. With 91 patents to his name, Wallace's ingenuity has left an indelible mark on the industry.

Latest Patents:

1. Aryl ethers and uses thereof: This patent focuses on HIF-2α inhibitors for treating cancer, showcasing compounds that have displayed efficacy in various assays and preclinical studies, offering hope for enhanced cancer treatment.

2. Quinazoline analogs as receptor tyrosine kinase inhibitors: Wallace's invention presents compounds effective as type I receptor tyrosine kinase inhibitors, potentially revolutionizing the treatment of hyperproliferative diseases like cancer.

Career Highlights:

Having worked at esteemed companies such as Array Biopharma Inc. and Peloton Therapeutics, Inc., Wallace's expertise and innovative prowess have been instrumental in driving cutting-edge research and development in the pharmaceutical sector.

Collaborations:

Throughout his career, Wallace has collaborated with accomplished professionals in the field, including Joseph P Lyssikatos and James F Blake. Their collective efforts have led to the successful development of novel pharmaceutical technologies.

Conclusion:

In conclusion, Eli M Wallace stands as a beacon of innovation in the realm of pharmaceutical inventions. His patents reflect a deep commitment to advancing medical science and improving the lives of countless individuals. Wallace's work serves as a testament to the transformative power of innovative thinking in the pursuit of better healthcare solutions.